Sphera Funds Management’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.32M Buy
+196,408
New +$6.01M 0.96% 36
2025
Q4
Sell
-100,000
Closed -$2.72M 114
2025
Q3
$2.72M Buy
+100,000
New +$2.42M 0.57% 60
2022
Q1
Sell
-235,695
Closed -$5.57M 81
2021
Q4
$5.57M Sell
235,695
-58,924
-20% -$1.37M 0.61% 53
2021
Q3
$7.51M Sell
294,619
-40,175
-12% -$938K 0.63% 51
2021
Q2
$7.03M Buy
334,794
+132,810
+66% +$2.73M 0.48% 60
2021
Q1
$4.75M Buy
+201,984
New +$3.9M 0.36% 73

Other funds holding IDYA

Sphera Funds Management's IDYA Position: Q2 2026 in Review

Sphera Funds Management opened a new position in IDEAYA Biosciences (IDYA) in Q2 2026: 196,408 shares worth $7.32M. The stake represents 0.96% of the portfolio and ranks #36 among its holdings. This is a return to the name: Sphera Funds Management previously reported a position in IDYA as recently as Q3 2025.

Sphera Funds Management first reported a position in IDYA in Q1 2021 and has held it in 6 quarters since. The position peaked at $7.51M in Q3 2021. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Sphera Funds Management held 196,408 shares of IDEAYA Biosciences worth $7.32M as of Q2 2026.
  • IDEAYA Biosciences was a new Sphera Funds Management position in Q2 2026.
  • IDEAYA Biosciences made up 0.96% of Sphera Funds Management's portfolio in Q2 2026, its #36 holding.
  • Sphera Funds Management first reported a position in IDEAYA Biosciences in Q1 2021 and has held it in 6 quarters since.
  • Sphera Funds Management's IDEAYA Biosciences position peaked at $7.51M in Q3 2021.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Sphera Funds Management's 13F filing for Q2 2026, filed 14 Aug 2026.